Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Blood Advances|April 2, 2020
Targeting EZH2 for the treatment of hepatosplenic T-cell lymphomaYana Pikman, Amy Saur Conway, Amanda L Robichaud, et al.
Haematologica|March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivationInge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Blood|May 3, 2007
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemiaJames B Nachman, Nyla A Heerema, Harland Sather, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Cancer|January 15, 2016
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivorsSteven E Lipshultz, Lynn M Anderson, Tracie L Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemiaFidaa Al-Shakfa, Stéphanie Dulucq, Ivan Brukner, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALLAmy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Oncotarget|June 3, 2017
Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patientsRachid Abaji, Vincent Gagné, Chang Jiang Xu, et al.
Pediatric Blood & Cancer|May 12, 2011
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Christine M Mrakotsky, Lewis B Silverman, Suzanne E Dahlberg, et al.
Pediatric Blood & Cancer|July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Blood Advances|April 2, 2020
Targeting EZH2 for the treatment of hepatosplenic T-cell lymphomaYana Pikman, Amy Saur Conway, Amanda L Robichaud, et al.
Haematologica|March 2, 2016
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivationInge M van der Sluis, Lynda M Vrooman, Rob Pieters, et al.
Blood|May 3, 2007
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemiaJames B Nachman, Nyla A Heerema, Harland Sather, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Cancer|January 15, 2016
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivorsSteven E Lipshultz, Lynn M Anderson, Tracie L Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemiaFidaa Al-Shakfa, Stéphanie Dulucq, Ivan Brukner, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Altered immune and treatment response gene expression signatures among poverty-exposed children with B-ALLAmy Guillaumet-Adkins, Noori Sotudeh, Sayalee Potdar, et al.
Oncotarget|June 3, 2017
Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patientsRachid Abaji, Vincent Gagné, Chang Jiang Xu, et al.
Pediatric Blood & Cancer|May 12, 2011
Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Christine M Mrakotsky, Lewis B Silverman, Suzanne E Dahlberg, et al.
Pediatric Blood & Cancer|July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
Pageof 19